Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermin Ointment is an approved topical combination of benzoic acid (6%) and salicylic acid (3%), classically known as Whitfield's ointment. Developed by Jayson Pharmaceuticals, it is indicated for the treatment of superficial fungal skin infections, including ringworm (tinea corporis), athlete's foot (tinea pedis), and barber's itch (tinea barbae), as well as to accelerate desquamation. Benzoic acid acts as a fungistatic agent to inhibit fungal growth, while salicylic acid acts as a keratolytic agent to soften and shed the infected outer layer of skin, enhancing the penetration of benzoic acid and facilitating the eradication of the infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzoic acid + salicylic acid.